Elanco Animal Health, Inc. (ELAN)
26.39
+1.64
(+6.63%)
USD |
NYSE |
Feb 24, 16:00
26.58
+0.19
(+0.72%)
After-Hours: 20:00
Elanco Animal Health Research and Development Expense (Quarterly) : 89.00M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Zoetis, Inc. | 199.00M |
| Eli Lilly & Co. | 3.802B |
| Johnson & Johnson | 4.268B |
| Merck & Co., Inc. | 3.992B |
| Ligand Pharmaceuticals, Inc. | 21.02M |